Romoli M, Muppa J, Lee EM, Mandel DM, Kam W, Mac Grory B, Zubair AS, ElNazeir M, Frontera JA, Salehi Omran S, Saleh Velez FG, Rothstein A, Khazaal O, Ghannam M, Almajali M, Samaniego EA, Bavarsad Shahripour R, Al Kasab S, Fonseca AC, Heldner MR, Antonenko K, De Marco G, Longoni M, Faini C, Tudisco V, Zedde M, Pascarella R, Marto JP, Sousa JA, Botelho Rosa S, Nunes AP, Aguiar De Sousa D, Nehme A, Shu L, Yaghi S, Henninger N. Recanalization After Acute Cervical Artery Dissection: A Multicenter International Study. Neurology. 2026 Nov 10; 107(9):e218566.

Locatelli F, Karakukcu M, Huynh V, González-Martínez B, Lins MM, Lu MY, Sulis ML, Pauly M, Morris C, Braunlin M, Talpes M, Gore L. Carfilzomib plus induction chemotherapy for children with relapsed or refractory acute lymphoblastic leukemia. Blood Adv. 2026 Oct 13; 10(19):6567-6577.

McNerney KO, Kwon S, Naik S, Fabrizio VA, Caraballo GL, Sanchez-Pinto LN, Talleur A, Zeng X, Baggott C, Vatsayan A, Verneris MR, Prabhu S, Rossoff J, Pacenta HL, Phillips CL, Talano JA, Moskop A, Myers GD, Karras NA, Bonifant C, Qayed M, Satwani P, Winestone L, Krupski C, Keating AK, Baumeister S, Egeler E, Stieglitz E, Curran KJ, Mackall CL, John S, Laetsch TW, Gardner R, Schultz LM. HLH-like syndromes associate with increased risk of death and CD19- relapse after CAR T in pediatric B-ALL. Blood Adv. 2026 Oct 13; 10(19):6422-6434.

Virupakshaiah A, Schoeps VA, Race J, Gambrah-Lyles C, Chang G, Waltz M, Nasr P, Moseley CE, Zamvil SS, Edwards AR, Francisco C, Casper TC, Rose JW, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Benson LA, Graves JS, Rensel M, Abrams AW, Krupp LB, O'Neill KA, Lotze TE, Fisher KS, Shukla NM, Aaen GS, Wheeler YS, Schreiner TL, Waldman AT, Chong J, Waubant E, Mar SS. Comparative Effectiveness of Treatments for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology. 2026 Oct 27; 107(8):e218508.

Wang ES, Erba H, Zeidan AM, Roboz GJ, Altman JK, Advani AS, Lin TL, Strickland SA, Juckett MB, Pratz KW, Mangan JK, McMahon CM, Alsfeld LC, Balasubramanian SK, Guru Murthy GS, Rotta M, Palmisiano ND, McCloskey J, Saliba AN, Khawandanah M, Madanat YF, Naqvi K, Qasrawi AH, Schiller GJ, Badar T, Gojo I, Yaghmour G, Osman D, Zhang H, Tian Y, Soifer HS, Riches M, Corum D, Leoni M, Fathi AT, Issa GC. Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia. Blood. 2026 Oct 01; 148(14):1775-1788.

Hurst JH, Zhao C, Raynor EM, Lee JW, Gitomer SA, Woods CW, Kelly MS, Smith MJ, Goldstein BA. Early life factors documented in electronic health records predict recurrent acute otitis media. PLoS One. 2026; 21(9):e0345434.

Khan F, Stretz C, Lewis S, Chahien D, Goldstein E, Siegler JE, Lineback CM, Eklund K, Khasiyev F, Al Kasab S, Culbertson CJ, D'Souza M, Stamm B, Ro J, Kerrigan D, Sharma R, Aboul-Nour H, Nahab F, Omran SS, Linares G, Sehgal S, Melkumova E, Singh E, Zha AM, Thottempudi N, Mannion S, Van Coevering R, Chen L, Thompson SL, Thon JM, Penckofer M, Yu W, Qdais AA, Jillella D, Sloane KL, Dumitrascu OM, Conyers FG, Talat F, Glover PA, Kang J, Patel V, Aziz Y, Zubair A, de Havenon A, Porto CV, Bowman A, Shahrivari M, Brorson JR, Liebeskind DS, Nedelcu S, Ali H, Abdalwahab A, Kam W, Nguyen TN, Herpich F, Farroqui M, Rojas-Soto D, Yaghi S. Comprehensive Diagnostic Evaluation and Risk of Recurrent Stroke After Embolic Stroke of Undetermined Source: Introducing the Concept of ESUS 2.0. J Am Heart Assoc. 2026 Sep 15; 15(18):e050182.

Vilaseca A, Bilodeau PA, Gakis G, Savransky A, Mahler Ferreira Oliveira J, Nguyen L, Hooshmand SI, Satyanarayan S, Moseley CE, Haley L, Roy-Hewitson C, Marrodan M, Casallas A, Manin A, Chen H, Hoshina Y, Grzezulkowska A, Carnero Contentti E, Galleguillos L, Upchurch M, Jackson-Tarlton CS, Chu-Yueh Guo J, Fabian M, Virupakshaiah A, Arrambide G, Caparó-Zamalloa C, Paterno R, Waubant E, Ordoñez Boschetti L, Correale J, Villa AM, Banwell B, Marignier R, Pittock SJ, Greenberg B, Bennett JL, Cho T, Clardy S, Solomon AJ, Kister I, Zamvil SS, Gelfand JM, Repovic P, Obeidat AZ, Blackburn K, Tenembaum S, Chen JJ, Sotirchos ES, Levy M, Flanagan EP, Murillo F, Syc-Mazurzek SB, Cacciaguerra L, Jiang M, da Silva Rezende NB, Wingerchuk DM, Horsman SE. Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2026 Sep 01; 83(9):860-872.

Bock AM, Feng L, Chauhan A, Falchi L, Merryman R, Godbole S, Thiruvengadam SK, Jallouk AP, Major A, D'Angelo C, Ayers A, Baron K, Farahat OM, Shouse G, Danilov A, Bair S, Lunning M, Bhaskar S, Herrera AF, Sawalha Y, Flowers CR, Crombie JL, Salles G, Epperla N, Ahmed S. Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab. Blood Adv. 2026 08 25; 10(16):5496-5504.

Bonaca MP, Canonico ME, Li N, Sasiela WJ, Nissen SE, Lincoff AM, Nicholls SJ. Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial. Circulation. 2026 Sep 15; 154(11):966-975.